Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-020-00767-6, published online 25 November 2020.
In the version of this article initially published, the name of cosignatory Tahir Mahmood was misspelled Tahi Mahmood. The error has been corrected in the PDF and HTML versions of the article.
Author information
Authors and Affiliations
President and CEO, Acorda Therapeutics, Ardsley, NY, USA
Ron Cohen
President and CEO, Apellis Pharmaceuticals, Waltham, MA, USA
Cedric Francois
Chairman and CEO, Amicus Therapeutics, Cranbury, NJ, USA
John Crowley
President and CEO, Nkarta Therapeutics, South San Francisco, CA, USA
Paul Hastings
CEO, GlycoMimetics, Rockville, MD, USA
Rachel King
President and CEO, Global Blood Therapeutics, South San Francisco, CA, USA
Ted W. Love
CEO, Alnylam Pharmaceuticals, Cambridge, MA, USA
John Maraganore
President and CEO, Biotechnology Innovation Organization, Washington, DC, USA
Michelle McMurry-Heath
Chairman and CEO, Ovid Therapeutics, New York, NY, USA
Jeremy Levin
Chairman, Biotechnology Innovation Organization, Washington, DC, USA
Jeremy Levin
Founder and CEO, Cydan II Inc., Cambridge, MA, USA
Chris Adams
President and CEO, Beacon Discovery, San Diego, CA, USA
Sunny Al-Shamma
Chairman and CEO, Veracyte, Inc., South San Francisco, CA, USA
Bonnie Anderson
President and CEO, Arrowhead Pharmaceuticals, Pasadena, CA, USA
Christopher R. Anzalone
Managing Director, Health Catalysts Group, Tucson, AZ, USA
Mara G. Aspinall
Entrepreneur in Residence, Third Rock Ventures, Boston, MA, USA
James E. Audia
President and CEO, Principia Biopharma Inc., South San Francisco, CA, USA
Martin Babler
CEO, Edison Oncology Holding Corp., Menlo Park, CA, USA
Jeffrey Bacha
President and CEO, AVEO Oncology, Cambridge, MA, USA
Michael P. Bailey
Partner, MPM Impact Fund, Boston, MA, USA
Christiana Bardon
CEO, Lasson Therapeutics, San Diego, CA, USA
Mark Barrett
Partner, Atlas Venture, Cambridge, MA, USA
Peter Barrett
Cofounder and CEO, Strand Therapeutics, Cambridge, MA, USA
Jacob Becraft
Founder, Bluebird Ventures, Palo Alto, CA, USA
Jeffrey Bird
Partner, Atlas Venture, Cambridge, MA, USA
Kevin Bitterman
President and CEO, Cytokinetics, Inc., South San Francisco, CA, USA
Robert Blum
President and CEO, Wave Life Sciences, Cambridge, MA, USA
Paul Bolno
Chairman of the Board, Alnylam Pharmaceuticals, Boston, MA, USA
Michael Bonney
Chairman of the Board, Kaleido Biosciences, Boston, MA, USA
Michael Bonney
Chairman of the Board, Magenta, Boston, MA, USA
Michael Bonney
Partner, Atlas Venture, Cambridge, MA, USA
Bruce Booth
Chairman of the Board, Arrakis Therapeutics, Cambridge, MA, USA
Katrine S. Bosley
CEO, Avidity Biosciences, La Jolla, CA, USA
Sarah Boyce
Head of Biotechnology and Pharma, William Blair and Company, Boston, MA, USA
Marina Bozilenko
CEO, Locanabio, San Diego, CA, USA
Jim Burns
Partner, Kleiner Perkins Caulfield Byers, Menlo Park, CA, USA
Brook Byers
President, Human BioMolecular Research Institute, San Diego, CA, USA
John Cashman
Cofounder and CEO, 1859 Inc., San Diego, CA, USA
Devon Cayer
Partner, Polaris Partners, Boston, MA, USA
Brian Chee
President and CEO, Genocea, Cambridge, MA, USA
Chip Clark
Chairman, President and CEO, Ashvatta Therapeutics, Redwood City, CA, USA
Jeffrey Cleland
Managing Director, Eden Biopharma, Dublin, Ireland, USA
Ivan Coulter
Owner, Gerald Cox Rare Care Consulting LLC, Boston, MA, USA
Gerald F. Cox
Entrepreneur Partner, Polaris Partners, Boston, MA, USA
Alan Crane
CEO, Lineage Cell Therapeutics, Carlsbad, CA, USA
Brian Culley
President and CEO, Second Genome, South San Francisco, CA, USA
Karim Dabbagh
CEO, Xencor, Monrovia, CA, USA
Bassil Dahiyat
CEO, ProQR Therapeutics, Cambridge, MA, USA
Daniel A. de Boer
CEO, Evox Therapeutics, Oxford, UK
Tony De Fougerolles
President, CEO, Radimmune Therapeutics, Inc., San Mateo, CA, USA
Steven R. Deitcher
Founder and CEO, Demy-Colton, Saint James, NY, USA
Sara Jane Demy
Founder, President and CEO, MaxCyte, Inc., Gaithersburg, MD, USA
Douglas Doerfler
President and CEO, Retrophin, San Diego, CA, USA
Eric Dube
President and CEO, Circle Pharma, Santa Cruz, CA, USA
David J. Earp
CEO, Abivax, Paris, France
Hartmut Ehrlich
Managing Partner, Aisling Capital LLC, New York, NY, USA
Steve Elms
Founder, CEO and Chairman, Vanguard Therapeutics, Inc., Half Moon Bay, CA, USA
Stephen H. Embury
Managing Director, Remedii LLC, Sunny Isles Beach, FL, USA
David R. Epstein
Partner, Third Rock Ventures, Boston, MA, USA
Neil Exter
Partner, Third Rock Ventures, San Diego, CA, USA
Alan Ezekowitz
President and CEO, Dicerna Pharmaceuticals, Lexington, MA, USA
Douglas Fambrough
President and CEO, Zogenix, Inc., Emeryville, CA, USA
Stephen J. Farr
CEO, Synthetic Genomics, Inc., La Jolla, CA, USA
Oliver Fetzer
President and CEO, MeiraGTx, New York, NY, USA
Alexandria Forbes
Partner, Atlas Venture, Cambridge, MA, USA
J. F. Formela
CEO, Lipidio Pharmaceuticals, San Diego, CA, USA
Gordon Foukes
CEO, Agios Pharmaceuticals, Cambridge, MA, USA
Jackie Fouse
Cofounder and CEO, Kezar Life Sciences, South San Francisco, CA, USA
John Fowler
Chairman, Evolution Life Science Partners, New York, NY, USA
Frederick Frank
Founder, President and CEO, Solid Bioscience, Cambridge, MA, USA
Ilan Ganot
CEO and President, Cofounder, Magenta Therapeutics, Cambridge, MA, USA
Jason Gardner
CEO, Recursion Pharmaceuticals, Salt Lake City, UT, USA
Christopher Gibson
President and CEO, Artelo Biosciences, La Jolla, CA, USA
Gregory Gorgas
Chairman, President and CEO, Intarcia Therapeutics, Boston, MA, USA
Kurt Graves
Partner, Atlas Venture, Cambridge, MA, USA
David Grayzel
Senior Advisor, Alnylam Pharmaceuticals, Cambridge, MA, USA
Barry Greene
President and COO, Alnylam Pharmaceuticals, Cambridge, MA, USA
Yvonne Greenstreet
President and CEO, Gossamer Bio, San Diego, CA, USA
Sheila Gujrathi
President and CEO, Spotlight Therapeutics, Hayward, CA, USA
Mary Haak-Frendscho
President and CEO, Regulus, La Jolla, CA, USA
John Hagan
Chairman and CEO, ElevateBio, Cambridge, MA, USA
David Hallal
Chairman and CEO, AlloVir, Cambridge, MA, USA
David Hallal
CEO, Leading Bio Sciences, Carlsbad, CA, USA
Tom Hallam
President and CEO, Halloran Consulting Group, Inc., Boston, MA, USA
Laurie Halloran
Chair and President, ACCESS Health International, New York, NY, USA
William Haseltine
Chairman, Gossamer Bio San Diego, CA, USA
Faheem Hasnain
Chairman, Mirati Therapeutics, San Diego, CA, USA
Faheem Hasnain
CEO, OrPro Therapeutics, San Diego, CA, USA
Peter B. Heifetz
CEO and Founder, GLAdiator Biosciences, Richmond, CA, USA
Terry Hermiston
President and CEO, Algomedix Inc., Mill Creek, WA, USA
Jeffrey Herz
Chairman of the Board, ORIC Pharmaceutical, San Diego, CA, USA
Richard Heyman
President and CEO, Bionano Genomics, San Diego, CA, USA
Erik Holmlin
President and CEO, ProSciento Inc., Chula Vista, CA, USA
Marcus Hompesch
General Partner, Canaan Partners, Menlo Park, CA, USA
Wende Hutton
President and CEO, Sarepta Therapeutics, Cambridge, MA, USA
Douglas S. Ingram
CEO, Strongbridge Biopharma, Trevose, PA, USA
John H. Johnson
Chair, Board of Directors, Palo Alto, CA, USA
Perry Karsen
CEO, Elex Biotech, Portland, OR, USA
Douglas Kawahata
CEO, Stoke Therapeutics, Bedford, MA, USA
Edward M. Kaye
General Partner, Canaan, Sausalito, CA, USA
Nina Kjellson
Founder, Avacta Life Sciences, Wetherby, UK
Paul Ko Ferrigno
CEO, metaLinear, Harrogate, UK
Paul Ko Ferrigno
CEO, Connect, San Diego, CA, USA
Mike Krenn
Executive Chairman, Centurion Biopharmaceuticals, Los Angeles, CA, USA
Steven Kriegsman
CEO, BridgeBio Pharma, Palo Alto, CA, USA
Neil Kumar
Senior Partner, PureTech Health, Boston, MA, USA
John LaMattina
Institute Professor, Massachusetts Institute of Technology, Cambridge, MA, USA
Robert Langer
CEO, Valley Fever Solutions, Tucson, AZ, USA
David Larwood
CEO and CSO, Virscio, Inc., New Haven, CT, USA
Matthew Lawrence
CEO, SVBLeerink, Boston, MA, USA
Jeff Leerink
Founder and CEO, Royalty Pharmaceuticals, New York, NY, USA
Pablo Legoretta
Executive Chairman, Vertex Pharmaceuticals, Boston, MA, USA
Jeff Leiden
Chief, Bluebird Bio, Cambridge, MA, USA
Nick Leschly
Partner, Third Rock Ventures, Boston, MA, USA
Mark Levin
President and CEO, Fluidigm Corp., South San Francisco, CA, USA
Christopher Linthwaite
Chairman, Real Endpoints, Westport, CT, USA
Roger Longman
CEO, Indi Molecular, Culver City, CA, USA
Albert Luderer
President and CEO, Sangamo Therapeutics, Richmond, CA, USA
Sandy Macrae
CEO, Applied Molecular Transport, South San Francisco, CA, USA
Tahir Mahmood
CEO, Dantari Pharmaceuticals, Thousand Oaks, CA, USA
Richard Markus
Chairman, President and CEO, Adjuvance Technologies, Lincoln, NE, USA
Tyler Martin
President, CEO and Chairman, Cytomx Therapeutics, South San Francisco, CA, USA
Sean McCarthy
CEO, Drawbridge Health, Menlo Park, CA, USA
Lee McCracken
Founding Partner, Polaris Partners, Boston, MA, USA
Terry McGuire
President and CEO, Antiva Biosciences, South San Francisco, CA, USA
Gail Mederis
President and CEO, Aristea Therapeutics, San Diego, CA, USA
James Mackay
President and CEO, Harpoon Therapeutics, South San Francisco, CA, USA
Jerry McMahon
President and CEO, Catabasis Pharmaceuticals, Boston, MA, USA
Jill C. Milne
Founder and CEO, AbilitaBio, San Diego, CA, USA
Mauro Miloni
Senior Advisor to Chairman, Center for Global Health Innovation, Atlanta, GA, USA
Kenneth I. Moch
Founder and CEO, Roswell Biotechnologies, San Diego, CA, USA
Paul Mola
CEO, Ionis Pharmaceuticals, Carlsbad, CA, USA
Brett Monia
Managing Director, Pandect Bioventures, South San Francisco, CA, USA
Walter Moos
Board Member and Advisor, Life Sciences, Hillsborough, CA, USA
Scott W. Morrison
Director, President and CEO, Arena Pharmaceuticals, San Diego, CA, USA
Amit Munshi
Chief Scientific Officer, Board Member, Dewpoint Therapeutics, Holliston, MA, USA
Mark Murcko
Managing Partner, Polaris Partners, Boston, MA, USA
Amir Nashat
CEO, Sutro Biopharma, Inc., South San Francisco, CA, USA
William J. Newell
Chairman and CEO, Cofounder, Cabaletta Bio, Philadelphia, PA, USA
Steven Nichtberger
CEO, IMV Inc., Dartmouth, Nova Scotia, Canada
Frederic Ors
Chairman of the Board of Directors, Biogen, Inc., Cambridge, MA, USA
Stelios Papadopoulos
Chairman of the Board of Directors, Exelixis, Inc., Alameda, CA, USA
Stelios Papadopoulos
Chairman of the Board of Directors, Regulus Therapeutics, Inc., San Diego, CA, USA
Stelios Papadopoulos
Chairman, Alliance for Regenerative Medicine Foundation, Chapel Hill, NC, USA
H. Stewart Parker
President and CEO, Hawaii Biotech, Honolulu, HI, USA
Elliot Parks
Managing Partner, 5AM Ventures, Boston, MA, USA
Kush M. Parmar
President and CEO, Arcturus Therapeutics, San Diego, CA, USA
Joseph Payne
Lead Independent Director, Global Blood Therapeutics, South San Francisco, CA, USA
Mark Perry
Chair, MyoKardia, Inc., Mill Valley, CA, USA
Mark Perry
Partner, Third Rock Ventures, Lexington, MA, USA
Cary G. Pfeffer
CEO, Bridge Medicines, New York, NY, USA
William J. Polvino
President and CEO, Intercept Pharmaceuticals Inc., New York, NY, USA
Mark Pruzanski
Founder, Aisling Capital LLC, Rye, NY, USA
Dennis J. Purcell
Director, Alnylam Pharmaceuticals, Cambridge, MA, USA
David E. I. Pyott
President and CEO, Ardelyx, Inc., Fremont, CA, USA
Michael G. Raab
President and CEO, Constellation Pharmaceuticals, Cambridge, MA, USA
Jigar Raythatha
CEO, BriOri Biotech, Carlsbad, CA, USA
R. Bruce Register
CEO, Translate Bio, Lexington, MA, USA
Ronald Renaud Jr
CEO (retired), Onyx Pharmaceuticals, Bend, Oregon, USA
Hollings Renton
President and CEO, Drug Delivery Experts, San Diego, CA, USA
Christopher Rhodes
Partner, Atlas Venture, Cambridge, MA, USA
Jason Rhodes
President and CEO, NextCure, Inc., Beltsville, MD, USA
Michael Richman
President and CEO, Nektar Therapeutics, San Francisco, CA, USA
Howard Robin
President and CEO, Blade Therapeutics, South San Francisco, CA, USA
Wendye Robbins
Chairman and CEO, Synergenics LLC, San Francisco, CA, USA
William J. Rutter
CEO, AzurRx BioPharma, Delray Beach, FL, USA
James Sapirstein
Chair, Vir Biotechnology, South San Francisco, CA, USA
Vicki Sato
President and CEO, iVeric Bio Inc., New York, NY, USA
Glenn Sblendorio
CEO, Vir Biotechnology, South San Francisco, CA, USA
George Scangos
Chairman and CEO, Geron Corporation, Menlo Park, CA, USA
John A. Scarlett
Managing Partner, Aisling Capital LLC, New York, NY, USA
Drew Schiff
Former CEO, Prosensa, Leiden, the Netherlands
Hans Schikan
Cofounder & Board Member, Pharvaris, Amsterdam, the Netherlands
Hans Schikan
CEO, Maverick Therapeutics, Brisbane, CA, USA
James Scibetta
Managing Partner, Polaris Partners, New York, NY, USA
Amy Schulman
Founding Partner, LSPIF, New York, NY, USA
Amy Schulman
CEO, TEGA Therapeutics, San Diego, CA, USA
Tim Scott
President and CEO, eGenesis, Inc., New York, NY, USA
Paul Sekhri
CEO, Nura Bio., San Francisco, CA, USA
Alpna Seth
Clinical Professor of Medicine, UCSF, San Francisco, CA, USA
Stephen A. Sherwin
Chairman, CEO, Cofounder, BioAlta, San Diego, CA, USA
Jay M. Short
Cofounder, Torreya Partners, New York, NY, USA
Mark Simon
President and CEO, Syros Pharmaceuticals, Wayland, MA, USA
Nancy Simonian
President and CEO, AlloVir, Boston, MA, USA
Vikas Sinha
CEO, BC Platforms, Zurich, Switzerland, USA
Tero Sivola
Chief Scientific Advisor, Operation Warp Speed, Gladwyne, PA, USA
Moncef Slaoui
President and CEO, E-Scape Bio, Inc., South San Francisco, CA, USA
Julie Anne Smith
CEO, ReNetX Bio, Inc., New Haven, CT, USA
Erika R. Smith
Chairman and CEO, Atea Pharmaceuticals, Inc., Boston, MA, USA
Jean-Pierre Sommadossi
Executive Chair, 5AM Ventures, Board Director, uniQure, Boston, MA, USA
Paula Soteropoulos
CEO and Cofounder, Peptomyc, Barcelona, Spain
Laura Souceck
CEO and Cofounder, Novoron Bioscience, San Diego, CA, USA
Travis Stiles
CEO, OncoResponse Inc., Seattle, WA, USA
Clifford J. Stocks
President and CEO, Nammi Therapeutics, Los Angeles, CA, USA
David Stover
CEO, DTx Pharma, San Diego, CA, USA
Arthur Suckow
CEO, TriSalus Life Sciences, Westminister, CO, USA
Mary T. Szela
Partner, Third Rock Ventures, Weston, MA, USA
Robert Tepper
Executive Vice President, Scripps Research Founder, Scripps Institute, La Jolla, CA, USA
Eric Topol
President and CEO, Voyager Pharmaceuticals, Cambridge, MA, USA
Andre Turenne
CEO, G1 Therapeutics, Research Triangle Park, NC, USA
Mark Velleca
President, Global Business Unit, Takeda, Cambridge, MA, USA
Rajeev Venkayya
Founder and CEO, yuFlu Inc., San Francisco, CA, USA
Dawn Verdugo
Director, Termeer Foundation, Boston, MA, USA
Alan Walts
CEO and Cofounder, Refuge Biotechnologies, Menlo, Park, CA, USA
Bing Wang
General Manager, I-Mab Biopharma U.S., Rockville, MD, USA
Neil Warma
CEO, Latigo Biotherapeutics, Thousand Oaks, CA, USA
Scott Wasserman
Nonexecutive Director, OncoSec Therapeutics, Pennington, NJ, USA
Robert Ward
Former Chairman and CEO, Eloxx Pharmaceuticals, Waltham, MA, USA
Robert Ward
CEO, Synbal Inc., San Diego, CA, USA
David Webb
Founder and CEO, Reveal BIO, San Diego, CA, USA
Claire Weston
Partner, Longwood Fund, Boston, MA, USA
Christoph Westphal
Director of Gene Therapy Program, University of Pennsylvania, Philadelphia, PA, USA
James M. Wilson
Founder and Director, MatriSys Bioscience, La Jolla, CA, USA
Mark S. Wilson
Chairman and CEO, Theravance BioPharma, Inc., South San Francisco, CA, USA
Rick Winningham
CEO, Amunix Pharmaceuticals, Mountain View, CA, USA
Angie You
President and CEO, Cerevast Medical, Inc., Bothell, WA, USA
Bradford Zakes
Emeritus Professor, Johns Hopkins University, Baltimore, MD, USA
Elias A. Zerhouni
Former Director, NIH, Bethesda, MD, USA
Elias A. Zerhouni
Founder and CEO, PureTech Health, Boston, MA, USA
Daphne Zohar
Venture Partner, Medicxi, Sausalito, CA, USA
Sandy Zweifach
- Ron Cohen
You can also search for this author in PubMed Google Scholar
- Cedric Francois
You can also search for this author in PubMed Google Scholar
- John Crowley
You can also search for this author in PubMed Google Scholar
- Paul Hastings
You can also search for this author in PubMed Google Scholar
- Rachel King
You can also search for this author in PubMed Google Scholar
- Ted W. Love
You can also search for this author in PubMed Google Scholar
- John Maraganore
You can also search for this author in PubMed Google Scholar
- Michelle McMurry-Heath
You can also search for this author in PubMed Google Scholar
- Jeremy Levin
You can also search for this author in PubMed Google Scholar
Consortia
Cosignatories
- Chris Adams
- , Sunny Al-Shamma
- , Bonnie Anderson
- , Christopher R. Anzalone
- , Mara G. Aspinall
- , James E. Audia
- , Martin Babler
- , Jeffrey Bacha
- , Michael P. Bailey
- , Christiana Bardon
- , Mark Barrett
- , Peter Barrett
- , Jacob Becraft
- , Jeffrey Bird
- , Kevin Bitterman
- , Robert Blum
- , Paul Bolno
- , Michael Bonney
- , Bruce Booth
- , Katrine S. Bosley
- , Sarah Boyce
- , Marina Bozilenko
- , Jim Burns
- , Brook Byers
- , John Cashman
- , Devon Cayer
- , Brian Chee
- , Chip Clark
- , Jeffrey Cleland
- , Ivan Coulter
- , Gerald F. Cox
- , Alan Crane
- , Brian Culley
- , Karim Dabbagh
- , Bassil Dahiyat
- , Daniel A. de Boer
- , Tony De Fougerolles
- , Steven R. Deitcher
- , Sara Jane Demy
- , Douglas Doerfler
- , Eric Dube
- , David J. Earp
- , Hartmut Ehrlich
- , Steve Elms
- , Stephen H. Embury
- , David R. Epstein
- , Neil Exter
- , Alan Ezekowitz
- , Douglas Fambrough
- , Stephen J. Farr
- , Oliver Fetzer
- , Alexandria Forbes
- , J. F. Formela
- , Gordon Foukes
- , Jackie Fouse
- , John Fowler
- , Frederick Frank
- , Ilan Ganot
- , Jason Gardner
- , Christopher Gibson
- , Gregory Gorgas
- , Kurt Graves
- , David Grayzel
- , Barry Greene
- , Yvonne Greenstreet
- , Sheila Gujrathi
- , Mary Haak-Frendscho
- , John Hagan
- , David Hallal
- , Tom Hallam
- , Laurie Halloran
- , William Haseltine
- , Faheem Hasnain
- , Peter B. Heifetz
- , Terry Hermiston
- , Jeffrey Herz
- , Richard Heyman
- , Erik Holmlin
- , Marcus Hompesch
- , Wende Hutton
- , Douglas S. Ingram
- , John H. Johnson
- , Perry Karsen
- , Douglas Kawahata
- , Edward M. Kaye
- , Nina Kjellson
- , Paul Ko Ferrigno
- , Mike Krenn
- , Steven Kriegsman
- , Neil Kumar
- , John LaMattina
- , Robert Langer
- , David Larwood
- , Matthew Lawrence
- , Jeff Leerink
- , Pablo Legoretta
- , Jeff Leiden
- , Nick Leschly
- , Mark Levin
- , Christopher Linthwaite
- , Roger Longman
- , Albert Luderer
- , Sandy Macrae
- , Tahir Mahmood
- , Richard Markus
- , Tyler Martin
- , Sean McCarthy
- , Lee McCracken
- , Terry McGuire
- , Gail Mederis
- , James Mackay
- , Jerry McMahon
- , Jill C. Milne
- , Mauro Miloni
- , Kenneth I. Moch
- , Paul Mola
- , Brett Monia
- , Walter Moos
- , Scott W. Morrison
- , Amit Munshi
- , Mark Murcko
- , Amir Nashat
- , William J. Newell
- , Steven Nichtberger
- , Frederic Ors
- , Stelios Papadopoulos
- , H. Stewart Parker
- , Elliot Parks
- , Kush M. Parmar
- , Joseph Payne
- , Mark Perry
- , Cary G. Pfeffer
- , William J. Polvino
- , Mark Pruzanski
- , Dennis J. Purcell
- , David E. I. Pyott
- , Michael G. Raab
- , Jigar Raythatha
- , R. Bruce Register
- , Ronald Renaud Jr
- , Hollings Renton
- , Christopher Rhodes
- , Jason Rhodes
- , Michael Richman
- , Howard Robin
- , Wendye Robbins
- , William J. Rutter
- , James Sapirstein
- , Vicki Sato
- , Glenn Sblendorio
- , George Scangos
- , John A. Scarlett
- , Drew Schiff
- , Hans Schikan
- , James Scibetta
- , Amy Schulman
- , Tim Scott
- , Paul Sekhri
- , Alpna Seth
- , Stephen A. Sherwin
- , Jay M. Short
- , Mark Simon
- , Nancy Simonian
- , Vikas Sinha
- , Tero Sivola
- , Moncef Slaoui
- , Julie Anne Smith
- , Erika R. Smith
- , Jean-Pierre Sommadossi
- , Paula Soteropoulos
- , Laura Souceck
- , Travis Stiles
- , Clifford J. Stocks
- , David Stover
- , Arthur Suckow
- , Mary T. Szela
- , Robert Tepper
- , Eric Topol
- , Andre Turenne
- , Mark Velleca
- , Rajeev Venkayya
- , Dawn Verdugo
- , Alan Walts
- , Bing Wang
- , Neil Warma
- , Scott Wasserman
- , Robert Ward
- , David Webb
- , Claire Weston
- , Christoph Westphal
- , James M. Wilson
- , Mark S. Wilson
- , Rick Winningham
- , Angie You
- , Bradford Zakes
- , Elias A. Zerhouni
- , Daphne Zohar
- & Sandy Zweifach
Corresponding author
Correspondence to Jeremy Levin.
Rights and permissions
About this article
Cite this article
Cohen, R., Francois, C., Crowley, J. et al. Author Correction: Supporting US public health experts. Nat Biotechnol 39, 115 (2021). https://doi.org/10.1038/s41587-020-00792-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-00792-5
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
